US president suggests he might visit the King in September
Latest editorial
Flynn and Pfizer fined £70m for overcharging NHS for epilepsy drugs
Flynn and Pfizer fined £70m for overcharging NHS for epilepsy drugs
RNLI confirms death following medical emergency
Warning from NASUWT general secretary
'Genuine reform is desperately needed'
Government urged to consider further measures
Walkout follows long-running dispute over sacking
PHARMACEUTICAL companies Flynn and Pfizer have been fined nearly £70 million after they overcharged the NHS for a life-saving epilepsy drug, the Competition and Markets Authority (CMA) announced today.
The body said that the two drug companies had illegally “abused their dominant positions” in the market to charge unfairly high prices over four years.
Costs to the NHS for the phenytoin sodium drug increased from £2m in 2012 to £50m in 2013.
More from this author
